• Accueil >
  • Publications >
  • 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

1 avr. 2021The Lancet Oncology

DOI : 10.1016/s1470-2045(21)00007-3

Auteurs

Martine Piccart, Laura J van 't Veer, Coralie Poncet, Josephine M N Lopes Cardozo, Suzette Delaloge, Jean-Yves Pierga, Peter Vuylsteke, Etienne Brain, Suzan Vrijaldenhoven, Peter A Neijenhuis, Sylvian Causeret, Tineke J Smilde, Giuseppe Viale, Annuska M Glas, Mauro Delorenzi, Christos Sotiriou, Isabel T Rubio, Sherko Kümmel, Gabriele Zoppoli, Alastair M Thompson, Erika Matos, Khalil Zaman, Florentine Hilbers, Debora Fumagalli, Peter Ravdin, Susan Knox, Konstantinos Tryfonidis, Aleksandra Peric, Bart Meulemans, Jan Bogaerts, Fatima Cardoso, Emiel J T Rutgers